Martin Feuchtenberger

Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study

Judith Haschka, Matthias Englbrecht, Axel J. Hueber et al. · Annals of the Rheumatic Diseases · 2015 · 189 citations

Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial

Gerd R Burmester, Frank Buttgereit, Corrado Bernasconi et al. · The Lancet · 2020 · 121 citations · Full text

Rheumatoid Disorder, Rheumatology, Low Disease Activity +8

Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial

Jürgen Rech, Koray Taşçılar, Melanie Hagen et al. · The Lancet · 2024 · 118 citations

Inflammation, Rheumatology, Rheumatoid Disorder +13

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment

Jürgen Rech, Axel J. Hueber, Stephanie Finzel et al. · Annals of the Rheumatic Diseases · 2015 · 89 citations · Full text

Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling

Elena Kotsiliti, Valentina Leone, Svenja Schuehle et al. · Journal of Hepatology · 2023 · 85 citations · Full text